BRIEF published on 11/14/2024 at 15:31, 1 year 11 months ago Novacyt launches new veterinary tests Gastrointestinal Diseases Novacyt Molecular Diagnosis Veterinary Tests Pathogens
BRIEF published on 11/01/2024 at 14:00, 2 years ago Novacyt: Update on liquidity contract and voting rights Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 11/01/2024 at 13:57, 2 years ago Novacyt Updates on Liquidity Agreement and Voting Rights Liquidity Agreement INVEST SECURITIES Total Voting Rights French Law Novacyt Shares
PRESS RELEASE published on 11/01/2024 at 13:52, 2 years ago Liquidity Agreement and Total Voting Rights Novacyt provides liquidity agreement update and total voting rights information, with Invest Securities purchasing and selling ordinary shares. Company divided into clinical, instrumentation, and research use segments Ordinary Shares Liquidity Agreement Total Voting Rights Novacyt Clinical Diagnostics
BRIEF published on 10/31/2024 at 10:28, 2 years ago Dr. Ian Gilham Joins Novacyt as Non-Executive Director Life Sciences Board Appointment Non-Executive Director Novacyt Dr. Ian Gilham
BRIEF published on 10/31/2024 at 10:25, 2 years ago Appointment of Dr Ian Gilham to the Board of Directors of Novacyt Board Of Directors Life Sciences Appointment Novacyt Ian Gilham
PRESS RELEASE published on 10/31/2024 at 10:23, 2 years ago Directorate Change Novacyt appoints Dr Ian Gilham as Non-Executive Director, bringing expertise in life sciences companies to strengthen the Board Life Sciences Non-Executive Director Novacyt Dr Ian Gilham AIM-listed
BRIEF published on 10/17/2024 at 11:47, 2 years ago IVDR Certification for Yourgene® Cystic Fibrosis Test by Novacyt Screening Novacyt IVDR Cystic Fibrosis Yourgene
BRIEF published on 10/10/2024 at 12:28, 2 years ago Novacyt closes its IT-IS International subsidiary EBITDA Closing Novacyt IT-IS International PCR Market
BRIEF published on 10/10/2024 at 12:27, 2 years ago Novacyt Closes IT-IS International Subsidiary Amid Market Saturation Financial Impact Intellectual Property Novacyt PCR Market IT-IS Closure
Published on 11/02/2026 at 12:30, 25 minutes ago Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
Published on 11/02/2026 at 12:10, 45 minutes ago Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
Published on 10/30/2026 at 23:35, 2 days 13 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 13 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 11/02/2026 at 12:45, 10 minutes ago Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial
Published on 11/02/2026 at 12:37, 17 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 11/02/2026 at 12:30, 25 minutes ago Immunic to Participate in Investor Conferences in November
Published on 11/02/2026 at 12:05, 50 minutes ago Trade Your View Before the IPO: Vantage Spotlights its Pre-IPO CFD Offering
Published on 10/30/2026 at 23:00, 2 days 13 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 18 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days ago Capital increase through exercise of subscription rights
